Related Experiment Video
Updated: Oct 21, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment
Alexandra Butters1,2,3, Neal K Lakdawala4, Jodie Ingles5,6,7,8
1Centre for Population, Genomics, Garvan Institute of Medical Research and UNSW Sydney, Sydney, Australia.
Insights
Hypertrophic cardiomyopathy (HCM) affects women differently than men. Women with HCM experience more severe symptoms and higher mortality risk, necessitating sex-specific research for better treatment.
Area of Science:
- Cardiology
- Genetics
- Environmental Health
Background:
- Hypertrophic cardiomyopathy (HCM) clinical guidelines are based on male-predominant data.
- Sex-specific differences in HCM presentation and outcomes are increasingly recognized.
- Women represent one-third of HCM patients but are underrepresented in research.
Purpose of the Study:
- To explore sex-specific interactions of genetics and environment in hypertrophic cardiomyopathy (HCM).
- To highlight disparities in HCM clinical course and outcomes between sexes.
- To emphasize the need for sex-disaggregated data in HCM research.
Main Methods:
- Review of observational studies and clinical data from hypertrophic cardiomyopathy (HCM) centers.
- Analysis of sex-specific presentation, disease stage, and symptom burden.
- Examination of genetic associations and risk factors for heart failure and mortality.
Main Results:
- Women with HCM are diagnosed later, present with more advanced disease, and have a higher symptom burden.
- Women face greater risks for heart failure and mortality compared to men with HCM.
- While women are more often gene-positive, sudden cardiac death risk and access to care are similar between sexes.
Conclusions:
- Significant sex differences exist in hypertrophic cardiomyopathy (HCM) progression and outcomes.
- Current research and guidelines may not adequately address the needs of female HCM patients.
- Sex-disaggregated data analysis is crucial for understanding HCM mechanisms and improving patient care.
Purpose Of Review:
We explore the sex-specific interaction of genetics and the environment on the clinical course and outcomes of hypertrophic cardiomyopathy (HCM).
Recent Findings:
Women account for approximately one-third of patients in specialist HCM centres and reported in observational studies. As a result, evidence informing clinical guideline recommendations is based predominantly on risk factors and outcomes seen in men. However, disease progression appears to be different between the sexes. Women present at a more advanced stage of disease, are older at diagnosis, have higher symptom burden, carry greater risk for heart failure and are at greater risk of mortality compared to men. Women are more likely to be gene-positive, while men are more likely to be gene-negative. The risk of sudden cardiac death and access to specialised care do not differ between the sexes. Reporting sex-disaggregated results is essential to identify the mechanisms leading to sex differences in HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Gene-Environment Interactions
Cardiomyopathy I: Introduction and Classification

